|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0115 | ED148309 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0224 | ED148870 | General Research Use | No | Male | White | 72 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0299 | ED149375 | General Research Use | No | Male | White | 64 | 4 - AREDS AMD Severity Scale Step 3 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0356 | ED148455 | General Research Use | No | Female | White | 76 | 4 - AREDS AMD Severity Scale Step 3 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_0544 | ED149524 | General Research Use | No | Female | White | 83 | 4 - AREDS AMD Severity Scale Step 2 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_0561 | ED148304 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 1 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0618 | ED148191 | General Research Use | No | Male | White | 68 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0678 | ED148084 | General Research Use | No | Female | White | 80 | 4 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0698 | ED148658 | General Research Use | No | Male | White | 69 | 4 - AREDS AMD Severity Scale Step 2 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0722 | ED148703 | General Research Use | No | Male | White | 59 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0725 | ED149302 | General Research Use | No | Female | White | 73 | 4 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0948 | ED148457 | General Research Use | No | Male | White | 62 | 4 - AREDS AMD Severity Scale Step 1 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1013 | ED149348 | General Research Use | No | Male | White | 69 | 4 - AREDS AMD Severity Scale Step 2 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1025 | ED148764 | General Research Use | No | Female | White | 68 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1264 | ED149174 | General Research Use | No | Female | White | 77 | 4 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1342 | ED148036 | General Research Use | No | Female | White | 71 | 4 - AREDS AMD Severity Scale Step 2 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_1406 | ED148294 | General Research Use | No | Male | White | 63 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1410 | ED149438 | General Research Use | No | Male | White | 74 | 4 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1455 | ED149609 | General Research Use | No | Female | White | 71 | 4 - AREDS AMD Severity Scale Step 2 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1479 | ED148596 | General Research Use | No | Male | White | 73 | 4 - AREDS AMD Severity Scale Step 3 | 7 - AREDS AMD Severity Scale Step 7 |